It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Experimental Ebola drug based on research discoveries from Canada’s national lab
The experimental Ebola drug given to two American aid workers is based on years of research done at Canada’s National Microbiology Laboratory in Winnipeg. ...
...Sources have told The Canadian Press that two of the three monoclonal antibodies in the drug were designed at the Winnipeg laboratory.
The work was done under the leadership of Dr. Gary Kobinger who heads the special pathogens research program at the national lab.
...The third monoclonal antibody in the product was developed by a U.S. government laboratory.
Rights to the Canadian-designed monoclonal antibodies have been acquired by a U.S. company called Leaf Biopharmaceutical of San Diego, California.
The company is partnered with Mapp Biopharmaceutical, also of San Diego, which makes the experimental therapy, called ZMapp.